Homepage
Medication Guide
What Are the Purchase Channels for Bedaquiline?
Bedaquiline is the world's first diarylquinoline anti-mycobacterial drug, specifically indicated for the treatment of adult and pediatric (aged 2 years and older with a body weight ≥ 8 kg) patient...
508
Monday, January 12th, 2026, 10:12
Side Effects of Mavacamten (Camzyos)
Mavacamten (Camzyos) is a medication indicated for the treatment of adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). As a drug with a unique mechanism of action, mavacamt...
506
Monday, January 12th, 2026, 10:02
What Are the Precautions for Mavacamten (Camzyos) Administration?
Mavacamten (Camzyos) is an innovative drug indicated for the treatment of symptomatic obstructive hypertrophic cardiomyopathy, and it belongs to the class of cardiac myosin inhibitors. As a prescripti...
511
Monday, January 12th, 2026, 09:53
Dosage and Administration of Camzyos (Mavacamten)
Camzyos (Mavacamten) is a cardiac myosin inhibitor approved in the United States in 2022. It is indicated for the treatment of adult patients with symptomatic obstructive hypertrophic cardiomyopathy (...
510
Monday, January 12th, 2026, 09:48
What Are the Indications for Mavacamten (Camzyos)?
Mavacamten (Camzyos) is an oral cardiac myosin inhibitor that received its first approval in the United States in 2022. As an innovative therapy, it offers a new treatment direction for patients with ...
505
Friday, January 9th, 2026, 10:33
What Are the Purchase Channels for Mavacamten (Camzyos)?
Mavacamten (Camzyos) is the world’s first approved cardiac myosin inhibitor for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM), and its standardized use is directly relate...
504
Friday, January 9th, 2026, 10:30
Adverse Reactions of Trametinib (Mekinist)
Trametinib (Mekinist) is a targeted therapy drug that demonstrates significant efficacy in the treatment of BRAFV600E or V600K mutation-positive melanoma, but the associated adverse reactions require ...
511
Friday, January 9th, 2026, 10:22
What are the precautions for Trametinib (Mekinist) administration?
Trametinib (Mekinist) is a reversible inhibitor of MEK1 and MEK2 kinases, playing a vital role in the treatment of BRAFV600E or V600K mutation-positive melanoma.What are the precautions for Trametinib...
506
Friday, January 9th, 2026, 10:19
Dosage and Administration of Trametinib (Mekinist)
Trametinib (Mekinist) is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma that is confirmed to harbor BRAF V600E or V600K mutations by an FDA-approve...
507
Friday, January 9th, 2026, 10:16
What Are the Indications for Trametinib (Mekinist)?
Trametinib (Mekinist) is a kinase inhibitor. As a representative targeted drug in the era of precision medicine, it has demonstrated favorable clinical value in the treatment of melanoma.What Are the ...
505
Thursday, January 8th, 2026, 13:53
17 / 207
2061 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved